Susan Y. Euling

3.2k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Susan Y. Euling is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology. According to data from OpenAlex, Susan Y. Euling has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Health, Toxicology and Mutagenesis, 11 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Susan Y. Euling's work include Effects and risks of endocrine disrupting chemicals (16 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Hypothalamic control of reproductive hormones (5 papers). Susan Y. Euling is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (16 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Hypothalamic control of reproductive hormones (5 papers). Susan Y. Euling collaborates with scholars based in United States, Denmark and Finland. Susan Y. Euling's co-authors include Sherry G. Selevan, Shanna H. Swan, Susan L. Makris, Niels E. Skakkebæk, Ora Hirsch Pescovitz, Grete Teilmann, Leo Dunkel, Marcia E. Herman‐Giddens, Anders Juul and Thorkild I. A. Sørensen and has published in prestigious journals such as New England Journal of Medicine, The Science of The Total Environment and PEDIATRICS.

In The Last Decade

Susan Y. Euling

28 papers receiving 2.1k citations

Hit Papers

Examination of US Puberty-Timing Data from 1940 to 1994 f... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Y. Euling United States 18 829 404 374 310 298 29 2.2k
Susan L. Makris United States 24 1.0k 1.2× 382 0.9× 186 0.5× 417 1.3× 240 0.8× 53 2.5k
Piera M. Cirillo United States 30 1.1k 1.4× 238 0.6× 211 0.6× 298 1.0× 876 2.9× 94 3.1k
Lin Ao China 33 849 1.0× 970 2.4× 643 1.7× 398 1.3× 174 0.6× 113 2.9k
Yuhong Zhao China 31 288 0.3× 751 1.9× 509 1.4× 341 1.1× 291 1.0× 147 3.4k
Ida Maria Schmidt Denmark 19 823 1.0× 597 1.5× 376 1.0× 168 0.5× 502 1.7× 36 2.2k
Peng Duan China 26 604 0.7× 519 1.3× 311 0.8× 317 1.0× 87 0.3× 98 2.0k
Maria Elisabeth Street Italy 30 236 0.3× 475 1.2× 343 0.9× 184 0.6× 490 1.6× 123 2.4k
Wei Yuan China 35 2.2k 2.6× 670 1.7× 252 0.7× 384 1.2× 615 2.1× 160 4.0k
Ulla Nordström Joensen Denmark 23 905 1.1× 457 1.1× 964 2.6× 164 0.5× 302 1.0× 67 2.7k
Qiang Zeng China 37 2.6k 3.1× 450 1.1× 384 1.0× 357 1.2× 281 0.9× 172 3.8k

Countries citing papers authored by Susan Y. Euling

Since Specialization
Citations

This map shows the geographic impact of Susan Y. Euling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Y. Euling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Y. Euling more than expected).

Fields of papers citing papers by Susan Y. Euling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Y. Euling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Y. Euling. The network helps show where Susan Y. Euling may publish in the future.

Co-authorship network of co-authors of Susan Y. Euling

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Y. Euling. A scholar is included among the top collaborators of Susan Y. Euling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Y. Euling. Susan Y. Euling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Euling, Susan Y., et al.. (2020). ExpoKids: An R-based tool for characterizing aggregate chemical exposure during childhood. Journal of Exposure Science & Environmental Epidemiology. 31(2). 233–247.
2.
Euling, Susan Y., et al.. (2019). Ordinal dose-response modeling approach for the phthalate syndrome. Environment International. 134. 105287–105287. 10 indexed citations
3.
Mortensen, Holly M., John Chamberlin, Bonnie R. Joubert, et al.. (2018). Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment. Mammalian Genome. 29(1-2). 190–204. 22 indexed citations
4.
Yost, Erin E., Susan Y. Euling, James Weaver, et al.. (2018). Hazards of diisobutyl phthalate (DIBP) exposure: A systematic review of animal toxicology studies. Environment International. 125. 579–594. 130 indexed citations
5.
Scialli, Anthony R., George P. Daston, Connie L. Chen, et al.. (2018). Rethinking developmental toxicity testing: Evolution or revolution?. Birth Defects Research. 110(10). 840–850. 36 indexed citations
6.
Makris, Susan L., Cheryl Siegel Scott, John Fox, et al.. (2016). A systematic evaluation of the potential effects of trichloroethylene exposure on cardiac development. Reproductive Toxicology. 65. 321–358. 27 indexed citations
7.
Euling, Susan Y., Chad M. Thompson, Weihsueh A. Chiu, & Robert Benson. (2013). An approach for integrating toxicogenomic data in risk assessment: The dibutyl phthalate case study. Toxicology and Applied Pharmacology. 271(3). 324–335. 13 indexed citations
8.
Mortensen, Holly M. & Susan Y. Euling. (2011). Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century. Toxicology and Applied Pharmacology. 271(3). 395–404. 18 indexed citations
9.
Wilson, Vickie S., Nagalakshmi Keshava, Susan Hester, et al.. (2011). Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment. Toxicology and Applied Pharmacology. 271(3). 299–308. 40 indexed citations
10.
Rudel, Ruthann A., Suzanne E. Fenton, Janet M. Ackerman, Susan Y. Euling, & Susan L. Makris. (2011). Environmental Exposures and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations. Environmental Health Perspectives. 119(8). 1053–1061. 157 indexed citations
11.
Euling, Susan Y., L.D. White, Vickie S. Wilson, et al.. (2011). Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data set. Toxicology and Applied Pharmacology. 271(3). 349–362. 40 indexed citations
12.
Burgess-Herbert, Sarah L. & Susan Y. Euling. (2011). Use of comparative genomics approaches to characterize interspecies differences in response to environmental chemicals: Challenges, opportunities, and research needs. Toxicology and Applied Pharmacology. 271(3). 372–385. 21 indexed citations
13.
Chiu, Weihsueh A., Susan Y. Euling, Cheryl Siegel Scott, & Ravi Subramaniam. (2010). Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicology and Applied Pharmacology. 271(3). 309–323. 21 indexed citations
14.
Makris, Susan L., Susan Y. Euling, L. Earl Gray, Robert Benson, & Paul M.D. Foster. (2010). Use of genomic data in risk assessment case study: I. Evaluation of the dibutyl phthalate male reproductive development toxicity data set. Toxicology and Applied Pharmacology. 271(3). 336–348. 14 indexed citations
15.
Ovacik, Meric, et al.. (2010). Pathway modeling of microarray data: A case study of pathway activity changes in the testis following in utero exposure to dibutyl phthalate (DBP). Toxicology and Applied Pharmacology. 271(3). 386–394. 15 indexed citations
16.
Makris, Susan L., Chad M. Thompson, Susan Y. Euling, Sherry G. Selevan, & Babasaheb Sonawane. (2008). A lifestage‐specific approach to hazard and dose‐response characterization for children's health risk assessment. Birth Defects Research Part B Developmental and Reproductive Toxicology. 83(6). 530–546. 17 indexed citations
17.
Bostwick, David G., Harry Burke, Daniel Djakiew, et al.. (2004). Human prostate cancer risk factors. Cancer. 101(S10). 2371–2490. 461 indexed citations
18.
Selevan, Sherry G., et al.. (2003). Blood Lead Concentration and Delayed Puberty in Girls. New England Journal of Medicine. 348(16). 1527–1536. 202 indexed citations
20.
Euling, Susan Y. & Carole A. Kimmel. (2001). Developmental stage sensitivity and mode of action information for androgen agonists and antagonists. The Science of The Total Environment. 274(1-3). 103–113. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026